The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -92,192 |
| Depreciation, amortization, and impairment | 77,321 |
| Inventory reserve expenses | 30,825 |
| Amortization of operating lease assets, debt costs, and other assets | 5,934 |
| Provision for expected credit losses | 2,255 |
| Deferred income taxes | 223 |
| Share-based compensation expense | 28,688 |
| Loss on disposal of fixed assets | -1,140 |
| Change in valuation of investment securities | 48 |
| Change in fair value of contingent consideration | -1,140 |
| Other | -1,838 |
| Accounts receivable | 1,583 |
| Inventories | 10,748 |
| Prepaid expenses and other current assets | 3,926 |
| Accounts payable | 2,599 |
| Other current liabilities | -2,268 |
| Contingent consideration milestone payment | 1,340 |
| Other long-term assets and liabilities | 4,231 |
| Net cash provided by (used in) operating activities | 33,347 |
| Capital expenditures | 34,626 |
| Other investing activities | -28 |
| Net cash used in investing activities | -34,598 |
| Proceeds from issuance of common shares | 5,929 |
| Payments related to withholdings for share-based compensation | 432 |
| Contingent consideration milestone payment | 4,990 |
| Payments related to finance lease obligation | 762 |
| Payment of debt issuance costs and other financing activities | 531 |
| Net cash provided by (used in) financing activities | -786 |
| Effect of exchange rate changes on cash and restricted cash | 1,414 |
| Net change in cash, cash equivalents, and restricted cash | -623 |
| Cash, cash equivalents, and restricted cash at the beginning of the year | 85,738 |
| Cash, cash equivalents, and restricted cash at the end of the year | 85,115 |
Orthofix Medical Inc. (OFIX)
Orthofix Medical Inc. (OFIX)